anticorps thérapeutiques

Communiqué de presse

Talem Therapeutics Announces Multi-Target Antibody Discovery Research Collaboration with Pierre Fabre Multi-target research collaboration leverages ImmunoPrecise’s powerful antibody discovery technologies with the long-standing expertise of Pierre Fabre in immuno-oncology

anticorps thérapeutiques, Francesco Hofmann, immuno-oncologie, ImmunoPrecise, ...

VICTORIA, BRITISH COLUMBIA (CANADA) and CASTRES (FRANCE), October 07, 2021 – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) […]